<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Disease Areas</title>
	<atom:link href="http://www.straightstocks.com/tag/disease-areas/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Sun, 21 Mar 2010 14:56:18 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Beacon Equity Research Featured Client: Taplmmune, Inc. (TPIM.OB)</title>
		<link>http://www.straightstocks.com/current-market-news/beacon-equity-research-featured-client-taplmmune-inc-tpimob/</link>
		<comments>http://www.straightstocks.com/current-market-news/beacon-equity-research-featured-client-taplmmune-inc-tpimob/#comments</comments>
		<pubDate>Tue, 10 Jun 2008 19:56:11 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Antigen Processing]]></category>
		<category><![CDATA[Body Defenses]]></category>
		<category><![CDATA[Cancer Cells]]></category>
		<category><![CDATA[Cancer Vaccine]]></category>
		<category><![CDATA[Cancers]]></category>
		<category><![CDATA[Disease Areas]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[Equity Research]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Melanoma]]></category>
		<category><![CDATA[Molecule]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Potency]]></category>
		<category><![CDATA[Proteins]]></category>
		<category><![CDATA[Tap Tap]]></category>
		<category><![CDATA[Toxicology]]></category>
		<category><![CDATA[Vaccines]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10554</guid>
		<description><![CDATA[Taplmmune, Inc. (TPIM.OB) is a developer of new innovative therapeutics and vaccines in the oncology and infectious disease areas.  The companyâ€™s therapeutics and vaccines are based on technologies that utilize transporters associated with Antigen Processing (TAP).  TAP therapy offers improvements in efficacy as well as reduced side effects and a boost in body [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/beacon-equity-research-featured-client-taplmmune-inc-tpimob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
